Axsome Therapeutics, Inc. (AXSM)
188.65
-0.45
(-0.24%)
USD |
NASDAQ |
Jan 22, 12:43
Axsome Therapeutics EPS Diluted (Quarterly): -0.9442 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Gilead Sciences, Inc. | 2.434 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Amicus Therapeutics, Inc. | 0.0558 |
| MannKind Corp. | 0.0256 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.23M |
| Revenue (Quarterly) | 170.99M |
| Total Expenses (Quarterly) | 218.22M |
| Enterprise Value | 9.426B |
| Gross Profit Margin (Quarterly) | 91.62% |
| Profit Margin (Quarterly) | -27.62% |
| Earnings Yield | -2.48% |
| Normalized Earnings Yield | -2.267 |